Sept 12: Probing the Legal Arguments in the Drug Industry’s Challenges to Medicare Drug Price Negotiations

With the Biden administration’s recent announcement of the first 10 drugs to be negotiated for Medicare as part of the Inflation Reduction Act (IRA), an array of legal challenges from…

Continue ReadingSept 12: Probing the Legal Arguments in the Drug Industry’s Challenges to Medicare Drug Price Negotiations

Medicare Advantage in 2023: Premiums, Out-of-Pocket Limits, Cost Sharing, Supplemental Benefits, Prior Authorization, and Star Ratings

People with Medicare have the option of receiving their Medicare benefits through the traditional Medicare program administered by the federal government or through a private Medicare Advantage plan, such as…

Continue ReadingMedicare Advantage in 2023: Premiums, Out-of-Pocket Limits, Cost Sharing, Supplemental Benefits, Prior Authorization, and Star Ratings

Spending on Medicare Advantage Quality Bonus Payments Will Reach at Least $12.8 Billion in 2023

To encourage Medicare Advantage plans to compete for enrollees based on quality, the Affordable Care Act (ACA) established a quality bonus program that increases payments to plans based on a…

Continue ReadingSpending on Medicare Advantage Quality Bonus Payments Will Reach at Least $12.8 Billion in 2023

KFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs

Key Findings As a relatively new class of prescription drugs, initially approved to treat type 2 diabetes, have been gaining attention for their use as effective weight loss drugs, the…

Continue ReadingKFF Health Tracking Poll July 2023: The Public’s Views Of New Prescription Weight Loss Drugs And Prescription Drug Costs